CFTR (mRNA replacement)
Assets acting on this target.
- Class
- Inhaled CFTR mRNA therapy
Assets acting on this target.
1 of 1 assets (1 discontinued)
| Drug | Owner | Mechanism | Indication | Reached | Why it stopped | Source |
|---|---|---|---|---|---|---|
| Luvomeran | Vertex Pharmaceuticals | CFTR (mRNA replacement) | Cystic Fibrosis | Ph 1/2 | Company-directed phase_1_2 disclosed in VRTX 10-K (2026-02-13) | source ↗ |